>
Radian Single Stage to Orbit Space Plane
Wednesday War Room LIVE: Trump Reveals New Information on Assassination Attempts:
DARPA's high-speed VTOL X-plane passes ground effect testing
Smart stitches generate electricity on movement for faster healing
Jeff Bezos's Blue Origin Could Have a Commercial Space Station Running by 2030
Toyota Just Invested $500 Million in Electric Air-Taxi Maker Joby
Cheap, powerful, high-density EV battery cells set for mass production
World's first 3D-printed hotel rises in the Texas desert
Venus Aerospace Unveils Potential Mach 6 Hypersonic Engine and Will Power a Drone in 2025
OpenAI As We Knew It Is Dead, Now It's A Loose Cannon In The Hands Of A Megalomaniac Technocrat
Geothermal Energy Could Outperform Nuclear Power
I Learned How to Fly This Electric Aircraft in a Week--and I Didn't Need a License
"I am Exposing the Whole Damn Thing!" (MIND BLOWING!!!!) | Randall Carlson
Israel develops method for hacking air-gapped computers - no computer is safe now
Known as "histotripsy," the method and machinery have already been tested successfully in animals and humans, and has just been approved for use by the FDA.
HistoSonics is a company founded in 2009 to create an ultrasound device that both screens for tumors and administers histotripsy. It was born from the efforts of scientists at the University of Michigan who co-founded the firm.
"Histotripsy is an exciting new technology that, although it is in early stages of clinical use, may provide a noninvasive treatment option for patients with liver cancer. Hopefully it can be combined with systemic therapies for a synergistic therapeutic effect," said Mishal Mendiratta-Lala, professor of radiology with Michigan Medicine.
Mendiratta-Lala was the principal investigator of an FDA human trial started in 2021 which confirmed that HistoSonic's device, called Edison, can destroy cancer tumors.